Trial Details

RECRUITING
Basic Information
Clinical ID c128
Identifier NCT07136116
Trial Title Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions -
Participant Information
Sponsor AbbVie
City Aichi-ken
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2025-10-09
Primary Completion Date 2030-02
Completion Date 2030-02